The dataset includes data from in vitro experiments on 11 cell lines: V79-379A, V79-753B, DLD1, SQ20B, CI-1, C3H10T1/2, SCC25, HCT116, H184B5 F5-1M/10 and HF19 (folder „data”). These data were taken from the survival curves available in the source articles and then a linear-quadratic model was fitted to them , from which the α and β parameters were obtained (04_Distributions, Figure 1). All operations on the experimental data, their reading, preparation(01_PreaparingData.ipynb) and analysis (02_Fitting_LQmodel.ipynb) were performed in Jupyter Notebooks. The experimental database has been cleared of outliers based on several conditions(03_Outliers.ipynb). A comparison of biological dose (05_SOBP.ipynb , Figure 2) was set up on a depth-do...
International audiencePurpose: Proton therapy treatments are based on a constant RBE (relative biolo...
International audienceBackground: Variable relative biological effectiveness (vRBE) in proton therap...
Most data supporting the widely accepted relative biological effectiveness (RBE) value of 1.1 for th...
Background: In proton radiation therapy a constant relative biological effectiveness (RBE) of 1.1 is...
Many cancer patients can benefit from proton therapy, as the treatment modality have been shown to p...
Background: The use of protons was first suggested for use in treating cancer in 1946, due to its pr...
Proton therapy is undergoing a rapid development making it increasingly popular as a treatment of ca...
For tumor therapy with light ions and for experimental aspects in particle radiobiology the relative...
Purpose: To better estimate relative biological effectiveness (RBE) in therapeutic proton beams by u...
Purpose: The clinical dose in carbon ion radiotherapy with wobbler method at National Institute of R...
Around the world, the use of protons as an alternative to photons radiation therapy of cancer is bec...
Despite increasing use of proton therapy (PBT), several systematic literature reviews show limited g...
In current clinical practice, the physical proton dose is converted to a biological equivalent photo...
International audiencePurpose: Proton therapy treatments are based on a constant RBE (relative biolo...
International audienceBackground: Variable relative biological effectiveness (vRBE) in proton therap...
Most data supporting the widely accepted relative biological effectiveness (RBE) value of 1.1 for th...
Background: In proton radiation therapy a constant relative biological effectiveness (RBE) of 1.1 is...
Many cancer patients can benefit from proton therapy, as the treatment modality have been shown to p...
Background: The use of protons was first suggested for use in treating cancer in 1946, due to its pr...
Proton therapy is undergoing a rapid development making it increasingly popular as a treatment of ca...
For tumor therapy with light ions and for experimental aspects in particle radiobiology the relative...
Purpose: To better estimate relative biological effectiveness (RBE) in therapeutic proton beams by u...
Purpose: The clinical dose in carbon ion radiotherapy with wobbler method at National Institute of R...
Around the world, the use of protons as an alternative to photons radiation therapy of cancer is bec...
Despite increasing use of proton therapy (PBT), several systematic literature reviews show limited g...
In current clinical practice, the physical proton dose is converted to a biological equivalent photo...
International audiencePurpose: Proton therapy treatments are based on a constant RBE (relative biolo...
International audienceBackground: Variable relative biological effectiveness (vRBE) in proton therap...
Most data supporting the widely accepted relative biological effectiveness (RBE) value of 1.1 for th...